A Randomised Trial Of Barretts Ablation: YAG Laser vs Argon Plasma Coagulatio

Phase 1

• Conditions: Barrets Oesophagus; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12605000586617
• Lead Sponsor: niversity of Melbourne Department of Surgery, Austin Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Barretts 3 - 10cm length.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Surface area ablated[At 6 weeks, 6 months and 12 months following completion of ablation];Buried gland rates[At 6 weeks, 6 months and 12 months following completion of ablation]

Secondary Outcome Measures

Name	Time	Method
Complications [During the ablation period and at 6 weeks, 6 months and 12 months post ablation.];Biomarker reversibility[At 6 weeks, 6 months and 12 months.]